Discovery & translation
Novel targets, human-relevant models and translational strategies designed to improve confidence before entering the clinic.
April 5–6, 2027 Amsterdam
The 2nd Annual
PAIN
THERAPEUTICS
SUMMIT EUROPE
The leading industry event focused on pain therapeutics, translational research, clinical development, & non-opioid innovation.
Call for speakers · 2027
Bring your perspective to the programme.
Working on new approaches to pain research or treatment? Explore the speaker submission page and share your interest in contributing to the 2027 summit.
Speaker submissionAmsterdam, the Netherlands · Where science meets action
About the summit
The room where the next standard of care takes shape.
The 2nd Annual Pain Therapeutics Summit EUROPE is bringing together senior leaders from biotech, pharmaceutical companies, academia, government, clinical research organizations, and investment groups to explore the latest advances in pain research, drug development, translational science, and commercialization strategies. Over the course of two days in Amsterdam, attendees will engage with experts developing the next generation of non-opioid therapeutics and exploring novel mechanisms of action, biomarkers, precision medicine strategies, and innovative clinical trial methodologies aimed at improving outcomes for patients living with acute and chronic pain.
Non-opioid targetsClinical translationPatient outcomes
From the 2026 event
A glimpse inside the summit.
Real moments from the conversations and connections that brought the community together.
Programme overview
Built around the questions moving pain R&D forward.
The 2027 agenda is currently in development. Expect a focused programme connecting discovery, translation, clinical development and the realities of bringing better pain treatments to patients.
Clinical development
Trial design, endpoints, biomarkers and patient-selection approaches that can produce clearer evidence in pain studies.
The evolving treatment landscape
Non-opioid innovation, responsible opioid development and the scientific, regulatory and commercial questions shaping access.
- New Approach Methodologies (NAMs) to improve success in pain R&D
- Novel non-opioid analgesics and emerging mechanisms
- Nav channel target validation and human nociceptor testing
- Placebo-response mitigation and procedural integrity
- Artificial intelligence in clinical trial optimization
- Making better early decisions in pain drug development
Meet our community
Featured 2026 speakers.
The 2027 faculty will be announced as the programme develops. In the meantime, meet some of the experts who shaped the 2026 European summit.
William Schmidt, Ph.D.
President
NorthStar Consulting
Lars Arendt-Nielsen, Dr. Med, Ph.D.
Professor, Head of Research Group, Center for Neuroplasticity & Pain
Aalborg University
Lynn Kirkpatrick, Ph.D.
Chief Executive Officer
Ensysce Biosciences
Geert Jan Groeneveld, MD, Ph.D.
Neurologist, Clinical Pharmacologist & Chief Executive Officer
Centre for Human Drug Research
Albert Dahan, MD, Ph.D.
Chief Executive Officer
MediD Consultancy
Irving Wainer, Ph.D.
Chief Scientific Officer
Spirify Pharma
Event details
A focused summit in the heart of Amsterdam.
Amsterdam Marriott HotelStadhouderskade 12, 1054 ES Amsterdam, Netherlands
Travel with easeCentral Amsterdam · Schiphol nearby
AMS
Meet at the Amsterdam Marriott Hotel, close to the city centre’s cultural landmarks, dining and transport links.
For partners & contributors
Put your science in the room.
Build meaningful relationships with decision-makers through exhibition, thought leadership and focused meeting formats.
Need to know